Equipoise: Asking the right questions for clinical trial design

Nature Reviews Clinical Oncology

Volumn 9, Issue 4, 2012, Pages 230-235

  Joffe, Steven ^a   Miller, Franklin G ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); CONTROL GROUP; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HUMAN; INTERVENTION STUDY; MEDICAL DECISION MAKING; MEDICAL ETHICS; PATIENT CARE PLANNING; PATIENT SAFETY; PATIENT SELECTION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROFESSIONAL STANDARD; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SAMPLE SIZE; STUDY DESIGN; TREATMENT RESPONSE;

HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RISK ASSESSMENT; THERAPEUTIC EQUIPOISE;

EID: 84859445702     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2011.211     Document Type: Review

References (36)

1. Joffe, S. & Truog, R. D. in The Oxford Textbook of Clinical Research Ethics Ch. 24 (eds Emanuel, E. J. et al.) 245-260 (Oxford University Press, Oxford, 2008).
2. Shatz, D. Randomized clinical trials and the problem of suboptimal care: an overview of the controversy. Cancer Invest. 8, 191-205 (1990).
3. Freedman, B. Equipoise and the ethics of clinical research. N. Engl. J. Med. 317, 141-145 (1987).
4. Weijer, C. The ethical analysis of risk. J. Law Med. Ethics 28, 344-361 (2000).
5. Weijer, C. & Miller, P. B. When are research risks reasonable in relation to anticipated benefits? Nat. Med. 10, 570-573 (2004).
6. Miller, P. B. & Weijer, C. Rehabilitating equipoise. Kennedy Inst. Ethics J. 13, 93-118 (2003).
7. Hellman, S. & Hellman, D. S. Of mice but not men. Problems of the randomized clinical trial. N. Engl. J. Med. 324, 1585-1589 (1991).
8. Marquis, D. Leaving therapy to chance. Hastings Cent. Rep. 13, 40-47 (1983).
9. Joffe, S. & Miller, F. G. Bench to bedside: mapping the moral terrain of clinical research. Hastings Cent. Rep. 38, 30-42 (2008).
10. Hill, A. B. Medical ethics and controlled trials. BMJ 1, 1043-1049 (1963).
11. Fried, C. Medical experimentation: personal integrity and social policy (eds. Bearn, A. G., Black, D. A. K. & Hiatt, H. H.) (American Elsevier Publishing Company, New York, 1974).
12. Council for International Organizations of Medical Sciences. International ethical guidelines for biomedical research involving human subjects. Geneva: Council for International Organizations of Medical Sciences; 2002 [accessed 21 December 2011]). http://www.cioms.ch/publications/guidelines/ guidelines-nov-2002-blurb.htm
13. National Bioethics Advisory Commission. Ethical and Policy Issues in Research Involving Human Participants. Bethesda, MD: National Bioethics Advisory Commission, August 2001 http://bioethics.georgetown.edu/nbac/pubs.html
14. Miller, F. G. Dispensing with equipoise. Am. J. Med. Sci. 342, 276-281 (2011).
15. Miller, F. G. & Joffe, S. Equipoise and the dilemma of randomized clinical trials. N. Engl. J. Med. 364, 476-480 (2011).
16. Miller, F. G. & Rosenstein, D. L. The therapeutic orientation to clinical trials. N. Engl. J. Med. 348, 1383-1386 (2003).
17. Miller, F. G. & Brody, H. A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials. Hastings Cent. Rep. 33, 19-28 (2003).
18. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: ethical principles and guidelines for the protection of human subjects of biomedical and behavioral research (U.S. Government Printing Office, Washington, DC, 1979). http://www.hhs.gov/ohrp/ humansubjects/guidance/belmont.html
19. National Bioethics Advisory Commission. Ethical and policy issues in international research: clinical trials in developing countries. Bethesda, MD: National Bioethics Advisory Commission, April 2001. http://bioethics.georgetown. edu/nbac/pubs.html
20. Veatch, R. M. The irrelevance of equipoise. J. Med. Philos. 32, 167-183 (2007).
21. Chalmers, I. & Matthews, R. What are the implications of optimism bias in clinical research? Lancet 367, 449-450 (2006).
22. Clark, W. F. et al. Effect of awareness of a randomized controlled trial on use of experimental therapy. JAMA 290, 1351-1355 (2003).
23. Moseley, J. B. et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N. Engl. J. Med. 347, 81-88 (2002).
24. Gifford, F. So-called "clinical equipoise" and the argument from design. J. Med. Philos. 32, 135-150 (2007).
25. Gifford, F. Community-equipoise and the ethics of randomized clinical trials. Bioethics 9, 127-148 (1995).
26. Goss, P. E. et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N. Engl. J. Med. 349, 1793-1802 (2003).
27. Bryant, J. & Wolmark, N. Letrozole after tamoxifen for breast cancer-what is the price of success? N. Engl. J. Med. 349, 1855-1857 (2003).
28. Halting a breast cancer trial. New York Times 4, (New York, 2003).
29. Johnson, N., Lilford, R. J. & Brazier, W. At what level of collective equipoise does a clinical trial become ethical? J. Med. Ethics 17, 30-34 (1991).
30. Rid, A. & Wendler, D. A framework for risk-benefit evaluations in biomedical research. Kennedy Inst. Ethics J. 21, 141-179 (2011).
31. Miller, F. G. & Wertheimer, A. Facing up to paternalism in research ethics. Hastings Cent. Rep. 37, 24-34 (2007).
32. Miller, F. G. & Pearson, S. D. Linking insurance coverage for innovative invasive procedures with participation in clinical research. JAMA 306, 2024-2025 (2011).
33. DiBenedetto, J. Jr et al. Ondansetron for nausea and vomiting associated with moderately emetogenic cancer chemotherapy. Clin. Ther. 17, 1091-1098 (1995).
34. Beck, T. M. et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy. The Ondansetron Study Group. Ann. Intern. Med. 118, 407-413 (1993).
35. Demetri, G. D. et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 368, 1329-1338 (2006).
36. Love, R. R. et al. Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer. J. Clin. Oncol. 20, 2559-2566 (2002).